PARIS–(Business enterprise WIRE)–Vetoquinol (Paris: VETO) is delighted to announce that, pursuing optimistic belief from the Committee for Medicinal Merchandise for Veterinary Use (CVMP), the European Fee has granted advertising and marketing authorisation for Felpreva^® (tigolaner/emodepside/praziquantel) for place-on avoidance and procedure of blended parasitic infestations/infections in cats.¹

Felpreva^® is the to start with place-on parasiticide for cats that addresses tapeworms in addition to other endoparasites which include gastrointestinal roundworms and lungworms, and ectoparasites (fleas, ticks and mites) for up to three months with a solitary dose. It is licensed for therapy of cats with, or at possibility from, blended parasitic infestations/bacterial infections, which includes:

– Endoparasites:

– Gastrointestinal roundworms: infection with Toxocara cati, Toxascaris leonina and Ancylostoma tubaeforme

– Lungworms: infection with Aelurostrongylus abstrusus and Troglostrongylus brevior

– Tapeworms: infection with Dipylidium caninum and Taenia taeniaeformis

– Ectoparasites:

– Flea (Ctenocephalides felis), tick (Ixodes ricinus, Ixodes holocyclus) and mite (Otodectes cynotis) infestations, as effectively as mild to reasonable cases of notoedric mange (triggered by Notoedres cati). It can also form element of a therapy tactic for flea allergic dermatitis (Fad).

Matthieu Frechin, Vetoquinol CEO, commented: “Marketing authorisation is a pivotal accomplishment for each Vetoquinol and Felpreva^®. It is a breakthrough remedy with advantage and simplicity of use blended with long-lasting efficacy. We think that Felpreva^® will be a real activity changer for this location of veterinary medication, demonstrating our determination to the parasiticide marketplace.”

Felpreva^® is element of the endectocide course of veterinary parasiticides that addresses each interior (endo) and external (ecto) parasites. It is a combination of lively substances emodepside and praziquantel, with tigolaner, a novel energetic component.¹

It is approximated that parasiticides make up the most significant segment in the companion animal veterinary pharmaceutical industry around the globe. Also, the speedy-developing endectocide classification is approximated to…